Faron Pharmaceuticals Oy Holding(s) in Company (6225Y)
December 06 2017 - 1:06PM
UK Regulatory
TIDMFARN TIDMLGEN
RNS Number : 6225Y
Faron Pharmaceuticals Oy
06 December 2017
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
-------------------------------------------------------------------------------------------------------
1a. Identity of the issuer Faron Pharmaceuticals Oy
or the underlying issuer 7437009H31TO1DC0EB42
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------- ----------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
-------------------------------------------------------------------------------------------------------
Non-UK issuer X
------------------------------------------------------------------------------------- ----------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
-------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------------------------- ----------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- ----------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- ----------------
Other (please specify)(iii) : Disclosure as per X
company's Articles of Association
------------------------------------------------------------------------------------- ----------------
3. Details of person subject to the notification obligation(iv)
Name
Legal & General Group Plc
(Group)
Legal & General Investment
Management Limited (LGIM)
City and country of registered 1 Coleman St, London EC2R
office (if applicable) 5AA
4. Full name of shareholder(s) (if different from 3.)(v)
-------------------------------------------------------------------------------------------------------
Name
Legal & General Assurance
Society (LGAS)
------------------------------------------------- ----------------------------------------------------
City and country of registered 1 Coleman St, London EC2R
office (if applicable) 5AA
------------------------------------------------- ----------------------------------------------------
5. Date on which the threshold 22 November 2017
was crossed or reached(vi)
:
------------------------------------------------- ----------------------------------------------------
6. Date on which issuer notified
(DD/MM/YYYY): 23 November 2017
------------------------------------------------- ----------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
-------------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights
(total of instruments of issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------- ------------------------- ---------------- ---------------- ----------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 4.68% - 4.68% 29,164,544
---------------------- ------------------------- ---------------- ---------------- ----------------
Position
of previous
notification
(if
applicable) 5.19% - 5.19%
---------------------- ------------------------- ---------------- ---------------- ----------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
----------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
--------------------- --------------------- -------------- ------------------------------ ---------------
ORD NPV 1,365,000 4.68%
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
A 1,365,000 4.68%
---------------------- ------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
B 1
-------------- ------------------------------ ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
--------------------- ---------------------- -------------- ----------------- ----------- ---------------
SUBTOTAL
8.B.2
----------------- ----------- ---------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which x
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
--------------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
-------------------------- ---------------- ----------------------- ---------------------
Legal & General
Group (Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- ---------------------
Legal & General
Investment Management
(Holdings) Limited
(Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- ---------------------
Legal & General
Assurance Society
(Direct) 0.66% 0.66%
-------------------------- ---------------- ----------------------- ---------------------
Legal & General
Group (Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- ---------------------
Legal & General
Investment Management
(Holdings) Limited
(Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General - -
Assurance (Pensions
Management)
Limited
(Direct)
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
Group (Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
Investment Management
(Holdings) Limited
(Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
Investment Management
Limited (Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
Group (Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
Investment Management
(Holdings) Limited
(Direct/Indirect) 4.68% 4.68%
-------------------------- ---------------- ----------------------- -----------------------
Legal & General
(Unit Trust
Managers) Limited
(Indirect) 4.01% 4.01%
-------------------------- ---------------- ----------------------- -----------------------
10. In case of proxy voting, please identify:
--------------------------------------------------------------------------------------------
Name of the proxy holder N/A
-------------------------------------------- ----------------------------------------------
The number and % of voting N/A
rights held
-------------------------------------------- ----------------------------------------------
The date until which the N/A
voting rights will be held
-------------------------------------------- ----------------------------------------------
11. Additional information(xvi)
--------------------------------------------------------------------------------------------
Notification using the total voting rights figure of
29,164,544
--------------------------------------------------------------------------------------------
Place of completion Brunel House, 2 Fitzalan Road, Cardiff,
CF24 0EB
-------------------- ----------------------------------------
Date of completion 22/11/2017
-------------------- ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGMMGZRVGGNZM
(END) Dow Jones Newswires
December 06, 2017 13:06 ET (18:06 GMT)
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Apr 2023 to Apr 2024